Comparison of Conventional Dose Regimen and New Dose Regimen of Pregabalin

• Status: Terminated
• Trial end date: 2019-10-30
• Target enrollment: 0
• Participant gender: All

Summary

The purpose of this study is to propose a new flexible dose regimen starting from 75mg using the low dose pregabalin 25 mg and 50 mg comparing the side effect and compliance with the conventional flexible dose regimen staring from 150mg using the pregabalin 75mg.

• Phase: N/A
• Accepts Healthy Volunteers?: No

Details

• Lead Sponsor: Kangbuk Samsung Hospital
• Treatments: Pregabalin

Criteria

Inclusion Criteria:

• Pain score NRS ≥3 Patients complaining of neuropathic pain (except neuropathic pain due to chemotherapy)

• Adult patients aged 19 to 85 years

• Patients who pre-agreed to the study

Exclusion Criteria:

• Patients complaining of severe pain (NRS ≥ 8)

• Creatinine clearance of <30 mL / min, the liver was more than 3 times normal

• Patients complaining of dizziness, patients with definite orthostatic hypotension

• Pregnant or lactating patients

• Patients who previously experienced side effects after administration pregabalin.